IRCT201612101475N11已完成3 期
Open safety and efficacy trial of topical nano-liposomal form of Amphotericin B in comparison with national standard treatment for the treatment of cutaneous leishmaniasis caused by Leishmania major (Phase 3)
ational Institute for Medical Research Development (NIMAD)0 个研究点目标入组 150 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 12 years 至 60 years（—）
- 性别
- All
入选标准
- •Males & females 12-60 years of age;Parasitologically proven CL caused by L. major (identification is done ?by using PCR); Otherwise healthy subjects on the basis of medical history; physical ?examination and results of blood test if requested by the physician; Ability to understand the principles of the trial and Signing an ?informed consent voluntarily and knowingly.?
排除标准
- •Pregnant or lactating women; Concurrent or chronic illness based on previous history;Duration of lesion more than 3 months;Number of lesions more than 5;Ulcer size greater than 3 cm in their largest diameter; History of full course of standard treatment (antimonials); ?Involvement in any other drug or vaccine trial during the study period.?
研究者
相似试验
已完成
2 期
Efficacy of topical Nano-liposomal Amphotericin B 0.4% for Treatment of OnychomycosisIRCT20150101020514N18Center For Research and Training in Skin Disease and Leprosy15
已完成
1 期
Safety Evaluation of Topical Application of Nano-Liposomal Amphotericin B (Sinaampholeish)Cutaneous leishmaniasis.Cutaneous leishmaniasisIRCT20081130001475N12eglected Diseases Initiative27
已完成
早期 1 期
Efficacy of Topical Liposomal Glucantime or Paromomycin in Combination With Systemic Glucantime for the Treatment of ACProtozoal diseases.Cutaneous LeishmaniasisIRCT138809051475N4Mashhad University of Medical sciences30
已完成
2 期
Evaluation the efficacy of topical naloxane on Controlling of Chronic Prupritus Induced By Chemical InjuriesChronic Prupritus Induced By Chemical Injuries.Irritant contact dermatitisL24L29PruritusIRCT201702221165N17Baghiyatallah University70
招募中
不适用
Efficacy, safety and dose finding trial of topical Jaungo application in atopic dermatitis patients: a randomized, double-blind, placebo-controlled studyKCT0002060Kyung Hee University Oriental Medicine Hospital at Gangdong34